Effects of microRNA95 targeting FOXD1 gene on radiosensitivity of colorectal cancer loVo cells and its mechanism

doi:10.12047/j.cjap.5864.2020.033

Abstract

CLC Number:

R73-36

LIANG Wan-ling, XIAO Tian-bao, YUAN Feng, CAO Yi-bo, YAN Deng-guo. Effects of microRNA95 targeting FOXD1 gene on radiosensitivity of colorectal cancer loVo cells and its mechanism[J]. CJAP, 2020, 36(2): 148-151.

References

[1] 陈世丰, 袁磊, 范文娟, 等. IGFBP7高表达诱导人结肠癌HT29细胞凋亡[J]. 中国应用生理学杂志, 2013, 29(2): 167-169.
[2] Ward WH, Sigurdson ER, Esposito AC. Pathologic response following treatment for locally advanced rectal cancer: Does location matter[J]. J Surg Res, 2018, 224(2): 215-221.
[3] Giannoulopoulos D, Nastos C, Gavriatopoulou M. The role of TAMIS (transanal minimally invasive surgery) in the management of advanced rectal cancer - one shared story of three exceptional cases[J]. J Invest Surg, 2019, 32(4): 371-376.
[4] 穆玉玲, 张良明, 陈剑. microRNA-95与肿瘤发生机制的研究[J]. 医学研究杂志, 2015, 44(5): 16-19.
[5] Jacobs L, Meek DB, van Heukelom J. Comparison of MRI and colonoscopy in determining tumor height in rectal cancer[J]. United European Gastroenterol J, 2018, 6(1): 131-137.
[6] Zhu Y, Qiao L, Zhou Y. Long non-coding RNA FOXD2-AS1 contributes to colorectal cancer proliferation through its interaction with microRNA-185-5p[J]. Cancer Sci, 2018, 109(7): 2235-2242.
[7] 邓曼丹, 姚雅俪, 陈喜云, 等. 下调FoxM1 mRNA对子宫颈癌细胞的增殖及侵袭能力的影响[J]. 中国妇幼保健, 2019, 34(20): 4804-4806.
[8] 王倩, 袁莉莉, 范文涛. 基于GEO和TCGA数据库分析促癌基因INHBA和抑癌基因CLCA4、CA4在结直肠癌中表达[J]. 中国应用生理学杂志, 2019, 35(3): 279-282.
[9] Suhool A, Moszkowicz D, Cudennec T. Optimal oncologic treatment of rectal cancer in patients over 75 years old: Results of a strategy based on oncogeriatric evaluation[J]. J Visc Surg, 2018, 155(1): 17-25.
[10]施凤涟, 卫英, 刘俊玲. miRNA-95在宫颈癌放疗敏感性中的作用及其机制研究[J]. 中华放射医学与防护杂志, 2018, 38(11): 807-814.
[11]Arndt GM, Dossey L, Cullen LM, et al. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer[J]. BMC Cancer, 2009, 9(1): 374-391.
[12]Huang Z, Huang S, Wang Q, et al. MicroRNA-95 promotes cell proliferation and targets sorting nexin 1 in human colorectal carcinoma[J]. Cancer Res, 2011, 71(7): 2582-2589.
[13]Li BY, Luo Y, Zhao WS. MicroRNA-210 negatively regulates the radiosensitivity of nasopharyngeal carcinoma cells[J]. Mol Med Rep, 2017, 16(2): 1401-1408.
[14]Chen C, Aihemaiti M, Zhang X. FOXD4 induces tumor progression in colorectal cancer by regulation of the SNAI3/CDH1 axis[J]. Cancer Biol Ther, 2018, 19(11): 1065-1071.
[15]Shi G, Wang H, Han H. Verteporfin enhances the sensitivity of LOVO/TAX cells to taxol via YAP inhibition[J]. Exp Ther Med, 2018, 16(3): 2751-2755.
[16]Galata C, Merx K, Mai S. Impact of adjuvant chemotherapy on patients with ypT0-2 ypN0 rectal cancer after neoadjuvant chemoradiation: a cohort study from a tertiary referral hospital[J]. World J Surg Oncol, 2018, 16(1): 156.
[17]王宇. FOXD1对浆液性卵巢癌增殖和转移的影响及其机制研究[D]. 山东大学, 2018.
[18]Liu M, An J, Huang M. MicroRNA-492 overexpression involves in cell proliferation, migration and radiotherapy response of cervical squamous cell carcinomas[J]. Mol Carcinog, 2018, 57(1): 32-38.
[19]倪猛, 殷涛, 王旸, 等. 抑制FOXD1基因表达增强结直肠癌细胞HCT116的放射敏感性[J]. 中华放射医学与防护杂志, 2018, 38(12): 886-893.
[20]Persiani R, Biondi A, Pennestrì F. Transanal total mesorectal excision vs laparoscopic total mesorectal excision in the treatment of low and middle rectal cancer: a propensity score matching analysis[J]. Dis Colon Rectum, 2018, 61(7): 809-816.